Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Health Policy,Drug Discovery
Link
https://link.springer.com/content/pdf/10.1007/s13167-021-00246-1.pdf
Reference113 articles.
1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro-Oncology, 2020. 22:iv1–96.
2. Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G. Aggressive pituitary tumors. Neuroendocrinology. Karger Publishers. 2015;101:87–104.
3. Souteiro P, Karavitaki N. Dopamine agonist resistant prolactinomas: any alternative medical treatment? Pituitary. 2020;23:27–37. Available from. https://doi.org/10.1007/s11102-019-00987-3.
4. Gariani K, Meyer P, Philippe J. Implications of somatostatin analogues in the treatment of acromegaly. Eur Endocrinol. 2013;9:132–5. Available from: https://pubmed.ncbi.nlm.nih.gov/29922369
5. Shanik MH. Limitations of current approaches for the treatment of acromegaly. Endocr Pract. 2016;22:210–9.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SZ-685C inhibits the growth of non-functioning pituitary adenoma by down-regulating miR-340-3p and inducing autophagy;Heliyon;2024-09
2. Predictors of biochemical response to somatostatin receptor ligands in acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07
3. New molecular tools for precision medicine in pituitary neuroendocrine tumors;Minerva Endocrinology;2024-01
4. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly;Archives of Medical Research;2023-12
5. A Differential Transcriptional Regulome Approach to Unpack Cancer Biology: Insights on Renal Cell Carcinoma Subtypes;OMICS: A Journal of Integrative Biology;2023-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3